The Federal Trade Commission is extending the public comment period, until May 25, 2022, on a request for information that covers a wide range of issues in the PBM market – including contract terms, rebates, fees, pricing policies, steering methods, conflicts of interest, and consolidation. The agency seeks information on these practices and their impact on patients, physicians, employers, independent and chain pharmacies, and other businesses across the distribution system.
On Feb. 24, 2022, the FTC announced the request for information, which will enable agency staff to study a wide array of PBM business practices and issues and will help inform the agency’s policy and enforcement work. Members of the public can comment on any issues or concerns they believe are relevant or appropriate for the agency’s consideration by submitting written data, views, facts, and opinions addressing this subject.
The Request for Information is available for public comment at: https://www.regulations.gov/docket/FTC-2022-0015.